HomeInvestorsMedia & Resources

Media & investor resources

Key information and updates for BlinkLab investors.

Investor presentations

Investor Presentation – Ignite Investment Summit (April 2026)

April 2026

Media & interviews

National Implementation Program & Pivotal U.S. Trial Advancement - Leadership Talks with BlinkLab CEO & Managing Director, Dr Henk-Jan Boele

East Coast Research - Leadership Talks
March 31, 2026

BlinkLab Teams Up with Morocco for Autism Screening Program – AusBiz Interview with Mr Brian Leedman

AusBiz - The Close
March 23, 2026

How AI-powered Smartphone Neurological Testing Advances Early Autism and ADHD Diagnosis – Leadership Talks with BlinkLab Chairman, Mr Brian Leedman

East Coast Research - Leadership Talks
February 9, 2026

The Stock Network's ASX Gems Investment Conference – Dr Henk-Jan Boele (BlinkLab Co-Founder, CEO & Managing Director)

The Stock Network
December 22, 2025

BlinkLab Delivers 84% Clinical-grade Accuracy in Pilot Study – Leadership Talks with BlinkLab CEO & Co-Founder, Dr Henk-Jan Boele

East Coast Research - Leadership Talks
November 17, 2025

BlinkLab Chairman, Mr Brian Leedman – Diagnosing Autism and ADHD from a Smartphone

Finance News Network
August 5, 2024

BlinkLab in the media

View all media mentions
April 21, 2026
Pulse+IT – Reesh Lyon

BlinkLab raises $17.5m towards US approval

April 18, 2026
BioSpectrum Asia

BlinkLab Secures A$17.5M to support the completion of its ongoing US FDA 510(k) registrational trial for autism diagnosis using BlinkLab’s Dx1 platform

April 17, 2026
Melbourne Insider - Daniel Rolph

BlinkLab Secures $17.5M for Autism Diagnostic Launch - AI-Powered Platform Targets Autism and ADHD

April 16, 2026
Stockhead - Health Check (Tim Boreham)

Tim Boreham's "Health Check" covers BlinkLab's capital raise among other AI health company news

April 16, 2026
Tanja7 (English)

BlinkLab Secures A$17.5 Million to Obtain FDA Clearance for Autism Diagnostics and Propel ADHD Trials Forward

Research analyst coverage

Independent investment analysis and research reports on BlinkLab, provided by third-party analysts.

April 2026

Bioshares, Australia's Independent Biotech Investment Resource (April 2026)

March 2026

Bioshares, Australia's Independent Biotech Investment Resource (March 2026)

November 2025

Outstanding USA Pilot Results Set the Path for 2026 FDA Clearance

October 2025

Bioshares, Australia's Independent Biotech Investment Resource (October 2025)

October 2024

Lodge Partners Initiation Research Report BlinkLab Ltd (ASX:BB1) ASD & ADHD

March 2024

Bioshares, Australia’s Independent Biotech Investment Resource (March 2024)

ASX announcements

Latest ASX announcements and company updates, including research milestones, commercial progress, and corporate actions.

View all ASX announcements

  • Loading...

    Loading...
    Download

Investor inquiries

For existing and prospective investor inquiries, contact BlinkLab below

Contact us

All inquiries are handled in accordance with continuous disclosure obligations.

Subscribe to the newsletter

Stay up to date with BlinkLab's latest news and developments.

Awesome! You're now signed up.

You will receive our newsletter. You can opt out via the newsletter.

Oops! Something went wrong while submitting the form.
Privacy Policy
•
Mobile Privacy Policy
•
Cookie Policy
•
HIPAA Compliance Commitment Disclaimer
info@blinklab.org
•
BLINKLAB LIMITED ACN 652 901 703
•
Level 4, 216 St Georges Terrace, Perth WA 6000
•
Copyright BlinkLab LTD
•
By Overflow Agency